| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 8.68e-08 | 7 | 143 | 4 | GO:0035005 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 4.44e-07 | 41 | 143 | 6 | GO:0001727 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 8.00e-07 | 11 | 143 | 4 | GO:0016303 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.02e-06 | 26 | 143 | 5 | GO:0052742 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.23e-05 | 7 | 143 | 3 | GO:0046934 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.52e-05 | 28 | 143 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.40e-05 | 188 | 143 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.11e-04 | 35 | 143 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8K1 ERBB2 OR5M9 OR9G4 FFAR2 DNER OR5M11 F2R OR51J1 PTH2R OR9A1P GHR PLXNC1 ADGRE3 OR6J1 NID1 IL17RA ADGRE1 KLRD1 GPR45 NOTCH2 OR9A2 | 2.50e-04 | 1353 | 143 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | retinoid binding | 3.84e-04 | 48 | 143 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 4.16e-04 | 49 | 143 | 4 | GO:0019840 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 5.32e-07 | 24 | 141 | 5 | GO:0048015 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 8.15e-07 | 26 | 141 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 8.15e-07 | 26 | 141 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.14e-05 | 21 | 141 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 1.39e-05 | 22 | 141 | 4 | GO:0036092 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 4.64e-05 | 2 | 141 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 8.89e-05 | 66 | 141 | 5 | GO:0046854 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 1.03e-04 | 68 | 141 | 5 | GO:0007528 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 1.71e-04 | 170 | 141 | 7 | GO:0046488 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex | 4.25e-05 | 29 | 142 | 4 | GO:0005942 | |
| GeneOntologyCellularComponent | mucus layer | 1.37e-04 | 3 | 142 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | Wnt signalosome | 1.61e-04 | 16 | 142 | 3 | GO:1990909 | |
| Domain | PI_Kinase | 5.19e-09 | 10 | 139 | 5 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 5.19e-09 | 10 | 139 | 5 | IPR001263 | |
| Domain | PIK_HELICAL | 5.19e-09 | 10 | 139 | 5 | PS51545 | |
| Domain | Growth_fac_rcpt_ | PCSK5 ERBB2 MATN2 DNER CRB1 NTN4 FBN1 ADGRE3 NID1 ADGRE1 NOTCH2 | 2.42e-08 | 156 | 139 | 11 | IPR009030 |
| Domain | EGF-like_dom | SELP PCSK5 MATN2 DNER TECTA PTGS2 CRB1 FBN1 ADGRE3 NID1 C1S ADGRE1 NOTCH2 | 4.52e-08 | 249 | 139 | 13 | IPR000742 |
| Domain | ASX_HYDROXYL | 5.79e-08 | 100 | 139 | 9 | PS00010 | |
| Domain | PI3/4_kinase_CS | 6.01e-08 | 15 | 139 | 5 | IPR018936 | |
| Domain | - | 8.69e-08 | 16 | 139 | 5 | 1.10.1070.11 | |
| Domain | PI3Kc | 8.69e-08 | 16 | 139 | 5 | SM00146 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.62e-08 | 106 | 139 | 9 | IPR000152 | |
| Domain | PI3K_Ras-bd_dom | 1.01e-07 | 7 | 139 | 4 | IPR000341 | |
| Domain | PI3K_rbd | 1.01e-07 | 7 | 139 | 4 | SM00144 | |
| Domain | PI3K_rbd | 1.01e-07 | 7 | 139 | 4 | PF00794 | |
| Domain | DIX | 1.01e-07 | 7 | 139 | 4 | PF00778 | |
| Domain | PI3K_RBD | 1.01e-07 | 7 | 139 | 4 | PS51546 | |
| Domain | DIX | 1.01e-07 | 7 | 139 | 4 | IPR001158 | |
| Domain | DIX | 1.01e-07 | 7 | 139 | 4 | PS50841 | |
| Domain | DAX | 1.01e-07 | 7 | 139 | 4 | SM00021 | |
| Domain | PI3_PI4_kinase | 1.68e-07 | 18 | 139 | 5 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.68e-07 | 18 | 139 | 5 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.68e-07 | 18 | 139 | 5 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.68e-07 | 18 | 139 | 5 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.68e-07 | 18 | 139 | 5 | PS50290 | |
| Domain | EGF | SELP PCSK5 MATN2 DNER TECTA PTGS2 CRB1 FBN1 ADGRE3 NID1 ADGRE1 NOTCH2 | 1.94e-07 | 235 | 139 | 12 | SM00181 |
| Domain | PI3K_C2 | 2.01e-07 | 8 | 139 | 4 | SM00142 | |
| Domain | PI3K_C2_dom | 2.01e-07 | 8 | 139 | 4 | IPR002420 | |
| Domain | PI3K_C2 | 2.01e-07 | 8 | 139 | 4 | PF00792 | |
| Domain | PI3K_C2 | 2.01e-07 | 8 | 139 | 4 | PS51547 | |
| Domain | EGF_CA | 3.23e-07 | 122 | 139 | 9 | SM00179 | |
| Domain | PI3Ka | 3.60e-07 | 9 | 139 | 4 | PF00613 | |
| Domain | PI3Ka | 3.60e-07 | 9 | 139 | 4 | SM00145 | |
| Domain | - | 3.60e-07 | 9 | 139 | 4 | 1.25.40.70 | |
| Domain | EGF-like_Ca-bd_dom | 3.71e-07 | 124 | 139 | 9 | IPR001881 | |
| Domain | EGF | 4.25e-07 | 126 | 139 | 9 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 6.36e-07 | 97 | 139 | 8 | IPR018097 | |
| Domain | EGF_CA | 7.44e-07 | 99 | 139 | 8 | PS01187 | |
| Domain | C8 | 1.39e-06 | 12 | 139 | 4 | PF08742 | |
| Domain | TIL | 1.39e-06 | 12 | 139 | 4 | PF01826 | |
| Domain | EGF_3 | SELP MATN2 DNER PTGS2 CRB1 FBN1 ADGRE3 NID1 C1S ADGRE1 NOTCH2 | 1.51e-06 | 235 | 139 | 11 | PS50026 |
| Domain | Dishevelled | 1.60e-06 | 4 | 139 | 3 | PF02377 | |
| Domain | Dishevelled_fam | 1.60e-06 | 4 | 139 | 3 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 1.60e-06 | 4 | 139 | 3 | IPR003351 | |
| Domain | Unchr_dom_Cys-rich | 1.99e-06 | 13 | 139 | 4 | IPR014853 | |
| Domain | C8 | 1.99e-06 | 13 | 139 | 4 | SM00832 | |
| Domain | TIL_dom | 2.78e-06 | 14 | 139 | 4 | IPR002919 | |
| Domain | EGF_1 | 3.32e-06 | 255 | 139 | 11 | PS00022 | |
| Domain | EGF_CA | 3.58e-06 | 86 | 139 | 7 | PF07645 | |
| Domain | EGF-like_CS | 4.15e-06 | 261 | 139 | 11 | IPR013032 | |
| Domain | VWF_type-D | 4.99e-06 | 16 | 139 | 4 | IPR001846 | |
| Domain | VWFD | 4.99e-06 | 16 | 139 | 4 | PS51233 | |
| Domain | VWD | 4.99e-06 | 16 | 139 | 4 | SM00216 | |
| Domain | VWD | 4.99e-06 | 16 | 139 | 4 | PF00094 | |
| Domain | Ubiquitin-rel_dom | 9.81e-06 | 184 | 139 | 9 | IPR029071 | |
| Domain | VWC_out | 1.04e-05 | 19 | 139 | 4 | SM00215 | |
| Domain | UDPGT | 1.59e-05 | 21 | 139 | 4 | PF00201 | |
| Domain | UDPGT | 1.59e-05 | 21 | 139 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 1.59e-05 | 21 | 139 | 4 | IPR002213 | |
| Domain | EGF_2 | 2.99e-05 | 265 | 139 | 10 | PS01186 | |
| Domain | cEGF | 3.87e-05 | 26 | 139 | 4 | PF12662 | |
| Domain | cEGF | 3.87e-05 | 26 | 139 | 4 | IPR026823 | |
| Domain | DVL-1 | 5.50e-05 | 2 | 139 | 2 | IPR008340 | |
| Domain | STPPase_N | 1.64e-04 | 3 | 139 | 2 | IPR031675 | |
| Domain | Dishevelled_C-dom | 1.64e-04 | 3 | 139 | 2 | IPR024580 | |
| Domain | GPCR_2_EMR1-like_rcpt | 1.64e-04 | 3 | 139 | 2 | IPR001740 | |
| Domain | Dsh_C | 1.64e-04 | 3 | 139 | 2 | PF12316 | |
| Domain | STPPase_N | 1.64e-04 | 3 | 139 | 2 | PF16891 | |
| Domain | VWF_dom | 2.64e-04 | 42 | 139 | 4 | IPR001007 | |
| Domain | Dsh/Dvl-rel | 3.27e-04 | 4 | 139 | 2 | IPR015506 | |
| Domain | PI3K_ABD | 3.27e-04 | 4 | 139 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 3.27e-04 | 4 | 139 | 2 | IPR003113 | |
| Domain | NIDO_dom | 5.42e-04 | 5 | 139 | 2 | IPR003886 | |
| Domain | NIDO | 5.42e-04 | 5 | 139 | 2 | SM00539 | |
| Domain | NIDO | 5.42e-04 | 5 | 139 | 2 | PF06119 | |
| Domain | NIDO | 5.42e-04 | 5 | 139 | 2 | PS51220 | |
| Domain | DEP | 5.60e-04 | 22 | 139 | 3 | PF00610 | |
| Domain | DEP | 5.60e-04 | 22 | 139 | 3 | PS50186 | |
| Domain | DEP | 5.60e-04 | 22 | 139 | 3 | SM00049 | |
| Domain | CT | 5.60e-04 | 22 | 139 | 3 | SM00041 | |
| Domain | DEP_dom | 6.41e-04 | 23 | 139 | 3 | IPR000591 | |
| Domain | GF_recep_IV | 8.09e-04 | 6 | 139 | 2 | PF14843 | |
| Domain | GF_recep_IV | 8.09e-04 | 6 | 139 | 2 | IPR032778 | |
| Domain | WxxW_domain | 8.09e-04 | 6 | 139 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 8.09e-04 | 6 | 139 | 2 | PF13330 | |
| Domain | Cys_knot_C | 8.23e-04 | 25 | 139 | 3 | IPR006207 | |
| Domain | CTCK_2 | 8.23e-04 | 25 | 139 | 3 | PS01225 | |
| Domain | AP_complex_ssu | 1.13e-03 | 7 | 139 | 2 | IPR016635 | |
| Domain | hEGF | 1.15e-03 | 28 | 139 | 3 | PF12661 | |
| Domain | VPS9 | 1.50e-03 | 8 | 139 | 2 | SM00167 | |
| Domain | CLAT_ADAPTOR_S | 1.91e-03 | 9 | 139 | 2 | PS00989 | |
| Domain | GPCR_2_secretin-like_CS | 2.04e-03 | 34 | 139 | 3 | IPR017983 | |
| Domain | VPS9 | 2.38e-03 | 10 | 139 | 2 | PS51205 | |
| Domain | VPS9 | 2.38e-03 | 10 | 139 | 2 | PF02204 | |
| Domain | VPS9 | 2.38e-03 | 10 | 139 | 2 | IPR003123 | |
| Domain | Kinase-like_dom | ERBB2 IRAK1 DAPK1 PIK3C2A PIK3C2B PIK3CB PIK3CG MAP4K5 PI4KB MAP3K15 TSSK4 | 2.45e-03 | 542 | 139 | 11 | IPR011009 |
| Domain | VWFC_2 | 2.81e-03 | 38 | 139 | 3 | PS50184 | |
| Domain | Death_domain | 2.81e-03 | 38 | 139 | 3 | IPR000488 | |
| Domain | VWC | 2.81e-03 | 38 | 139 | 3 | SM00214 | |
| Domain | Laminin_G_2 | 3.26e-03 | 40 | 139 | 3 | PF02210 | |
| Domain | Clathrin_sm-chain_CS | 3.46e-03 | 12 | 139 | 2 | IPR000804 | |
| Domain | PP2Ac | 4.06e-03 | 13 | 139 | 2 | SM00156 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.68e-06 | 28 | 114 | 5 | M19580 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 2.95e-06 | 110 | 114 | 8 | M39492 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 5.36e-06 | 32 | 114 | 5 | MM14719 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.78e-05 | 20 | 114 | 4 | MM14721 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.88e-05 | 41 | 114 | 5 | M7399 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 3.33e-05 | 46 | 114 | 5 | M48317 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 3.38e-05 | 76 | 114 | 6 | M9052 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.80e-05 | 24 | 114 | 4 | MM14599 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 3.80e-05 | 24 | 114 | 4 | M15926 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.50e-05 | 25 | 114 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.50e-05 | 25 | 114 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.50e-05 | 25 | 114 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.29e-05 | 26 | 114 | 4 | M39404 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.53e-05 | 51 | 114 | 5 | M17726 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 7.30e-05 | 54 | 114 | 5 | M3896 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 8.24e-05 | 29 | 114 | 4 | MM1522 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.18e-04 | 15 | 114 | 3 | MM15697 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.88e-04 | 72 | 114 | 5 | M9257 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 3.85e-04 | 18 | 114 | 3 | M31 | |
| Pathway | REACTOME_PI_METABOLISM | 3.94e-04 | 77 | 114 | 5 | MM14590 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.29e-04 | 44 | 114 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.68e-04 | 45 | 114 | 4 | MM15694 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 5.31e-04 | 20 | 114 | 3 | M90 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 5.57e-04 | 83 | 114 | 5 | M39637 | |
| Pathway | REACTOME_PI_METABOLISM | 5.88e-04 | 84 | 114 | 5 | M676 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.16e-04 | 21 | 114 | 3 | MM15706 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS | 6.38e-04 | 5 | 114 | 2 | M27447 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 6.49e-04 | 49 | 114 | 4 | M40046 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 7.01e-04 | 50 | 114 | 4 | MM14641 | |
| Pathway | BIOCARTA_GSK3_PATHWAY | 7.09e-04 | 22 | 114 | 3 | MM1421 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.09e-04 | 22 | 114 | 3 | MM15888 | |
| Pathway | REACTOME_PREDNISONE_ADME | 8.11e-04 | 23 | 114 | 3 | MM16639 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 8.14e-04 | 52 | 114 | 4 | M39782 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.14e-04 | 52 | 114 | 4 | M14171 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 8.14e-04 | 52 | 114 | 4 | M19877 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 8.75e-04 | 53 | 114 | 4 | M662 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 9.52e-04 | 6 | 114 | 2 | M39600 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.01e-03 | 55 | 114 | 4 | M14933 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 1.04e-03 | 25 | 114 | 3 | M39794 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.31e-03 | 27 | 114 | 3 | M1088 | |
| Pubmed | 3.59e-08 | 9 | 145 | 4 | 22511988 | ||
| Pubmed | 3.59e-08 | 9 | 145 | 4 | 1339448 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 23642732 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 8798481 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 5.97e-08 | 10 | 145 | 4 | 9247029 | |
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 5.97e-08 | 10 | 145 | 4 | 8636073 | |
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 11465080 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 5.97e-08 | 10 | 145 | 4 | 22558097 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 12051676 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 18825309 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 18300795 | ||
| Pubmed | Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. | 7.10e-08 | 3 | 145 | 3 | 23320105 | |
| Pubmed | 9.35e-08 | 11 | 145 | 4 | 16081599 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 9.35e-08 | 11 | 145 | 4 | 12584329 | |
| Pubmed | 9.35e-08 | 11 | 145 | 4 | 9808187 | ||
| Pubmed | 9.35e-08 | 11 | 145 | 4 | 9708406 | ||
| Pubmed | 9.35e-08 | 11 | 145 | 4 | 10985305 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 14602571 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 16514418 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 19419973 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 10208934 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 12077252 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 9341793 | ||
| Pubmed | 1.40e-07 | 12 | 145 | 4 | 12551992 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.40e-07 | 12 | 145 | 4 | 11434514 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.44e-07 | 57 | 145 | 6 | 21886157 | |
| Pubmed | 2.01e-07 | 13 | 145 | 4 | 9394803 | ||
| Pubmed | 2.01e-07 | 13 | 145 | 4 | 23215766 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.01e-07 | 13 | 145 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.01e-07 | 13 | 145 | 4 | 25246029 | |
| Pubmed | 2.81e-07 | 14 | 145 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.81e-07 | 14 | 145 | 4 | 10836148 | |
| Pubmed | 2.81e-07 | 14 | 145 | 4 | 9295054 | ||
| Pubmed | 2.81e-07 | 14 | 145 | 4 | 17157319 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.81e-07 | 14 | 145 | 4 | 14672974 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 2.83e-07 | 4 | 145 | 3 | 18223459 | |
| Pubmed | Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. | 2.83e-07 | 4 | 145 | 3 | 11113207 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 9535849 | ||
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 2.83e-07 | 4 | 145 | 3 | 12391274 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 23807779 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 8817329 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 33154304 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 2.83e-07 | 4 | 145 | 3 | 9192851 | |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 2.83e-07 | 4 | 145 | 3 | 24901817 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 36367122 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 17471237 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 2.83e-07 | 4 | 145 | 3 | 29869461 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 2.83e-07 | 4 | 145 | 3 | 20929551 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 2.83e-07 | 4 | 145 | 3 | 27298226 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 2.83e-07 | 4 | 145 | 3 | 17401217 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 12676567 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 25298197 | ||
| Pubmed | 3.50e-07 | 66 | 145 | 6 | 19898482 | ||
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 3.82e-07 | 15 | 145 | 4 | 18854243 | |
| Pubmed | 5.07e-07 | 16 | 145 | 4 | 20019835 | ||
| Pubmed | 5.07e-07 | 16 | 145 | 4 | 21029719 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.07e-07 | 16 | 145 | 4 | 19414484 | |
| Pubmed | 5.07e-07 | 16 | 145 | 4 | 20818790 | ||
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 5.07e-07 | 16 | 145 | 4 | 16524887 | |
| Pubmed | 5.07e-07 | 16 | 145 | 4 | 11289809 | ||
| Pubmed | 5.42e-07 | 71 | 145 | 6 | 33541421 | ||
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 6.61e-07 | 17 | 145 | 4 | 18453587 | |
| Pubmed | 6.61e-07 | 17 | 145 | 4 | 23251686 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 6.61e-07 | 17 | 145 | 4 | 20639394 | |
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 6.61e-07 | 17 | 145 | 4 | 12960231 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 7.05e-07 | 5 | 145 | 3 | 16475027 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 19581931 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 7677729 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 10805725 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 22261707 | ||
| Pubmed | HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. | 8.48e-07 | 18 | 145 | 4 | 12526811 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.07e-06 | 19 | 145 | 4 | 23281178 | |
| Pubmed | 1.07e-06 | 19 | 145 | 4 | 24073214 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 19110483 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 17982272 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.41e-06 | 6 | 145 | 3 | 19204906 | |
| Pubmed | 1.64e-06 | 21 | 145 | 4 | 9446795 | ||
| Pubmed | 2.00e-06 | 22 | 145 | 4 | 11994280 | ||
| Pubmed | 2.00e-06 | 22 | 145 | 4 | 11154208 | ||
| Pubmed | 2.41e-06 | 23 | 145 | 4 | 23301033 | ||
| Pubmed | 2.41e-06 | 23 | 145 | 4 | 19047410 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.45e-06 | 7 | 145 | 3 | 8467709 | |
| Pubmed | 2.45e-06 | 7 | 145 | 3 | 8464825 | ||
| Pubmed | ERBB2 PPP1CC GMPS CD22 PIK3C2B PIK3CB PIK3CG SEC23IP RABGEF1 | 2.59e-06 | 276 | 145 | 9 | 28319085 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 2.89e-06 | 24 | 145 | 4 | 24625756 | |
| Pubmed | Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. | 3.42e-06 | 25 | 145 | 4 | 17632570 | |
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 3.42e-06 | 25 | 145 | 4 | 15689238 | |
| Pubmed | 3.91e-06 | 8 | 145 | 3 | 20610558 | ||
| Pubmed | 3.91e-06 | 8 | 145 | 3 | 22579593 | ||
| Pubmed | 3.91e-06 | 8 | 145 | 3 | 17179145 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 3.91e-06 | 8 | 145 | 3 | 12695355 | |
| Pubmed | 4.72e-06 | 27 | 145 | 4 | 11156964 | ||
| Pubmed | 5.85e-06 | 9 | 145 | 3 | 22899650 | ||
| Pubmed | RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer. | 5.85e-06 | 9 | 145 | 3 | 32965059 | |
| Pubmed | Regulation of the Wnt signaling pathway by disabled-2 (Dab2). | 5.85e-06 | 9 | 145 | 3 | 12805222 | |
| Pubmed | Protein phosphatase 2Calpha dephosphorylates axin and activates LEF-1-dependent transcription. | 1.14e-05 | 11 | 145 | 3 | 10644691 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.52e-05 | 12 | 145 | 3 | 20308471 | |
| Pubmed | 1.52e-05 | 12 | 145 | 3 | 12421720 | ||
| Interaction | RASSF9 interactions | 6.45e-06 | 39 | 137 | 5 | int:RASSF9 | |
| Cytoband | 2q37 | 2.81e-06 | 31 | 145 | 4 | 2q37 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 9.58e-08 | 8 | 112 | 4 | 831 | |
| GeneFamily | UDP glucuronosyltransferases | 4.39e-05 | 32 | 112 | 4 | 363 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 2.26e-04 | 4 | 112 | 2 | 505 | |
| GeneFamily | CD molecules|Mucins | 2.84e-04 | 21 | 112 | 3 | 648 | |
| GeneFamily | Olfactory receptors, family 9 | 3.74e-04 | 23 | 112 | 3 | 156 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 3.76e-04 | 5 | 112 | 2 | 915 | |
| GeneFamily | VPS9 domain containing | 1.66e-03 | 10 | 112 | 2 | 928 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.84e-03 | 13 | 112 | 2 | 693 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.60e-07 | 187 | 142 | 8 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-06 | 170 | 142 | 7 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 170 | 142 | 7 | 28fb192b21cdc5a77ba4f276694cff852eb2304b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 170 | 142 | 7 | 239cb4b801b2d71a6facb386f2684c0851504151 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 179 | 142 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 182 | 142 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-06 | 117 | 142 | 6 | 089793a950e8593b4acc1ba6a5e5474682f5fda6 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-06 | 117 | 142 | 6 | 3d98d77b4725d684e7496059e8b0ffffbe40301d | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.21e-06 | 185 | 142 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-06 | 189 | 142 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 193 | 142 | 7 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 193 | 142 | 7 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 193 | 142 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 193 | 142 | 7 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 193 | 142 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 197 | 142 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 197 | 142 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 197 | 142 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 197 | 142 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.46e-06 | 198 | 142 | 7 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.46e-06 | 198 | 142 | 7 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.46e-06 | 198 | 142 | 7 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.70e-06 | 200 | 142 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 98 | 142 | 5 | fcb9da8b676f57facfdfc0ccaca585acaa6396f2 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 98 | 142 | 5 | dd6e81120ff27961da766f47a251688ee8390b90 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 98 | 142 | 5 | 8ff05867d623fa13c361789fe76634ce1f4a9354 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 98 | 142 | 5 | 0a4198a806cf9a143d546555f5e0bef2f2b6fd6e | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 98 | 142 | 5 | 7e24ebfe74d1bd6af78b0b9d7c10852d49f85cf9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-05 | 169 | 142 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 170 | 142 | 6 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 170 | 142 | 6 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 104 | 142 | 5 | fdf4599de8cd4ccf1bd7ede4e7af63d69c108b43 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 104 | 142 | 5 | a3d061170fe49d023ac31dbaeb2b5d2347988078 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.10e-05 | 175 | 142 | 6 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.17e-05 | 176 | 142 | 6 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-05 | 178 | 142 | 6 | fbf49766e1504df554856b84c0576c06f3167329 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-05 | 179 | 142 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-05 | 181 | 142 | 6 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 181 | 142 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 182 | 142 | 6 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 187 | 142 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 56 | 142 | 4 | cc072782b296e75e1bb11e62d280ca199b73481e | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 56 | 142 | 4 | 0c137f6263626df9837e5c00fa6ba6201bfebf52 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 56 | 142 | 4 | 435fdc82c2c078e5f37a60de36ce80ca0c3aade8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 189 | 142 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 189 | 142 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 189 | 142 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 190 | 142 | 6 | 96a9756cad5468a12591021e6d661ed269b5b3d9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 191 | 142 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 3.43e-05 | 191 | 142 | 6 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 191 | 142 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.43e-05 | 191 | 142 | 6 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 191 | 142 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.64e-05 | 193 | 142 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.64e-05 | 193 | 142 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.64e-05 | 193 | 142 | 6 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | ef0fa9daecd3bf43c6cf56345928cacdbee19779 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 195 | 142 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-05 | 195 | 142 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.85e-05 | 195 | 142 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 195 | 142 | 6 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.85e-05 | 195 | 142 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 195 | 142 | 6 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 195 | 142 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 196 | 142 | 6 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-05 | 196 | 142 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.96e-05 | 196 | 142 | 6 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-05 | 196 | 142 | 6 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-05 | 197 | 142 | 6 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-05 | 197 | 142 | 6 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 197 | 142 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-05 | 197 | 142 | 6 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| Drug | apigenin | UGT1A5 DVL3 SLC2A2 UGT1A4 UGT1A1 UGT1A3 PIK3C2A PIK3C2B PIK3CB PIK3CG SPEN SLC2A11 | 1.74e-09 | 184 | 141 | 12 | CID005280443 |
| Drug | tectochrysin | 1.22e-07 | 20 | 141 | 5 | CID005281954 | |
| Drug | Benzamidoxime hydrochloride | 1.59e-07 | 21 | 141 | 5 | CID000069186 | |
| Drug | AC1MRQNQ | 1.73e-07 | 9 | 141 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.73e-07 | 9 | 141 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 1.73e-07 | 9 | 141 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.73e-07 | 9 | 141 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.73e-07 | 9 | 141 | 4 | CID005460873 | |
| Drug | phenanthridine | 2.61e-07 | 23 | 141 | 5 | CID000009189 | |
| Drug | AS-3201 | 3.28e-07 | 24 | 141 | 5 | CID000153948 | |
| Drug | N-acetylbenzidine | 4.08e-07 | 25 | 141 | 5 | CID000018787 | |
| Drug | 4-nitrophenyl)imidazole | 4.50e-07 | 11 | 141 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 4.50e-07 | 11 | 141 | 4 | CID006442661 | |
| Drug | diflunisal | 6.14e-07 | 27 | 141 | 5 | CID000003059 | |
| Drug | N-OH-DABZ | 6.71e-07 | 12 | 141 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 6.71e-07 | 12 | 141 | 4 | CID000088735 | |
| Drug | 2,4,6-TCB | 6.71e-07 | 12 | 141 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 6.71e-07 | 12 | 141 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 6.71e-07 | 12 | 141 | 4 | CID000276709 | |
| Drug | acridine | 7.14e-07 | 81 | 141 | 7 | CID000009215 | |
| Drug | trans-3'-hydroxycotinine | 8.94e-07 | 29 | 141 | 5 | CID000000414 | |
| Drug | tritanol | 9.65e-07 | 13 | 141 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 9.65e-07 | 13 | 141 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 9.65e-07 | 13 | 141 | 4 | CID000000411 | |
| Drug | halenaquinone | 1.34e-06 | 14 | 141 | 4 | CID000370346 | |
| Drug | propranolol glucuronide | 1.34e-06 | 14 | 141 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.34e-06 | 14 | 141 | 4 | CID000036401 | |
| Drug | urochloralic acid | 1.74e-06 | 59 | 141 | 6 | CID003036914 | |
| Drug | 6-methylsalicylic acid | 1.75e-06 | 33 | 141 | 5 | CID000011279 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.82e-06 | 15 | 141 | 4 | CID000040469 | |
| Drug | 4-hydroxyisoleucine | 1.82e-06 | 15 | 141 | 4 | CID000354197 | |
| Drug | afloqualone | 1.82e-06 | 15 | 141 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.82e-06 | 15 | 141 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.82e-06 | 15 | 141 | 4 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.82e-06 | 15 | 141 | 4 | CID000543743 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 2.04e-06 | 34 | 141 | 5 | ctd:C569670 | |
| Drug | estragole | 2.04e-06 | 34 | 141 | 5 | CID000008815 | |
| Drug | naringenin | 2.14e-06 | 136 | 141 | 8 | CID000000932 | |
| Drug | AP10 | 2.30e-06 | 5 | 141 | 3 | CID000193748 | |
| Drug | quercetin-3,4'-diglucoside | 2.42e-06 | 16 | 141 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.42e-06 | 16 | 141 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.42e-06 | 16 | 141 | 4 | CID005497144 | |
| Drug | platensimycin | 2.58e-06 | 63 | 141 | 6 | CID006857724 | |
| Drug | AC1L9DGV | 2.74e-06 | 36 | 141 | 5 | CID000417381 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | SELP TBXAS1 COL11A1 PTGS2 ADCY7 PIK3C2A PIK3C2B PIK3CB PIK3CG | 2.82e-06 | 189 | 141 | 9 | CID000001413 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.15e-06 | 17 | 141 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.15e-06 | 17 | 141 | 4 | CID000037766 | |
| Drug | staurosporine; Down 200; 0.01uM; MCF7; HG-U133A | 3.80e-06 | 196 | 141 | 9 | 425_DN | |
| Drug | SureCN12722713 | 4.03e-06 | 18 | 141 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.03e-06 | 18 | 141 | 4 | CID000152226 | |
| Drug | Br 2 | 4.03e-06 | 18 | 141 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.03e-06 | 18 | 141 | 4 | CID000036614 | |
| Drug | ApApG | 4.03e-06 | 18 | 141 | 4 | CID003081975 | |
| Drug | C1 11-32 | 4.03e-06 | 18 | 141 | 4 | CID000443077 | |
| Drug | C11131 | 4.03e-06 | 18 | 141 | 4 | CID000443076 | |
| Drug | AC1OAGGW | 5.06e-06 | 203 | 141 | 9 | CID006857364 | |
| Drug | 9-OH-risperidone | 5.08e-06 | 19 | 141 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 5.08e-06 | 19 | 141 | 4 | CID000091433 | |
| Drug | almokalant | 5.08e-06 | 19 | 141 | 4 | CID003033962 | |
| Drug | mepyramine | 5.40e-06 | 154 | 141 | 8 | CID000004992 | |
| Drug | 3-O-methyl-D-glucose | 5.66e-06 | 72 | 141 | 6 | CID000008973 | |
| Drug | monomethyl phthalate | 5.67e-06 | 155 | 141 | 8 | CID000020392 | |
| Drug | trifluoperazine | UGT1A5 TSHB PTGS2 ADCY7 PPP1CA PPP1CC UGT1A4 UGT1A1 UGT1A3 SEC23IP XYLB | 5.82e-06 | 324 | 141 | 11 | CID000005566 |
| Drug | L 654969 | 6.00e-06 | 42 | 141 | 5 | CID000005218 | |
| Drug | PTBP | 6.00e-06 | 42 | 141 | 5 | CID000007393 | |
| Drug | AC1NFJIQ | 6.00e-06 | 42 | 141 | 5 | CID004659568 | |
| Drug | eugenol | 6.14e-06 | 73 | 141 | 6 | CID000003314 | |
| Drug | AC1L1OBF | 6.32e-06 | 20 | 141 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 6.32e-06 | 20 | 141 | 4 | CID000116545 | |
| Drug | androsterone glucuronide | 6.76e-06 | 43 | 141 | 5 | CID000114833 | |
| Drug | estriol-16-glucuronide | 7.77e-06 | 21 | 141 | 4 | CID000122281 | |
| Drug | dulcin | 7.77e-06 | 21 | 141 | 4 | CID000009013 | |
| Drug | ranirestat | 7.99e-06 | 7 | 141 | 3 | ctd:C115070 | |
| Drug | amonafide | 9.45e-06 | 22 | 141 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 9.45e-06 | 22 | 141 | 4 | CID000053167 | |
| Drug | amidoxime | 1.14e-05 | 23 | 141 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.14e-05 | 23 | 141 | 4 | CID000066651 | |
| Drug | wartmannin | PCSK5 ERBB2 DNAJC13 IRAK1 DGKZ F2R PTGS2 SLC2A2 TG GHR PIK3C2A PIK3C2B PIK3CB PIK3CG PI4KB SEC23IP SLC2A11 | 1.15e-05 | 811 | 141 | 17 | CID000005691 |
| Drug | Thromboxane A2 | 1.27e-05 | 8 | 141 | 3 | ctd:D013928 | |
| Drug | phenylbutazone | 1.29e-05 | 83 | 141 | 6 | CID000004781 | |
| Drug | niflumic acid | 1.31e-05 | 125 | 141 | 7 | CID000004488 | |
| Drug | ibuprofen | TBXAS1 CPAMD8 UGT1A5 PTGS2 TG UGT1A4 UGT1A1 UGT1A3 OXSM NOTCH2 | 1.54e-05 | 294 | 141 | 10 | CID000003672 |
| Drug | C2-MPAcid | 1.58e-05 | 51 | 141 | 5 | CID000508230 | |
| Drug | 5-MOP | 1.61e-05 | 25 | 141 | 4 | CID000002355 | |
| Drug | AzMC | 1.61e-05 | 25 | 141 | 4 | CID000064986 | |
| Drug | 5,6-benzoquinoline | 1.61e-05 | 25 | 141 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 1.61e-05 | 25 | 141 | 4 | CID000013662 | |
| Drug | sulfinpyrazone | 1.70e-05 | 87 | 141 | 6 | CID000005342 | |
| Drug | nogalonic acid methyl ester | 1.70e-05 | 87 | 141 | 6 | CID000443820 | |
| Drug | luteolin | 1.77e-05 | 131 | 141 | 7 | CID005280445 | |
| Drug | ZSTK474 | 1.90e-05 | 9 | 141 | 3 | ctd:C510150 | |
| Drug | 5 alpha-androstane-3 beta,17 beta-diol | 2.06e-05 | 185 | 141 | 8 | CID000011301 | |
| Drug | HCG 004 | 2.10e-05 | 54 | 141 | 5 | CID000064928 | |
| Drug | sulindac sulfone | 2.10e-05 | 54 | 141 | 5 | ctd:C025463 | |
| Drug | DiMeIQx | 2.21e-05 | 27 | 141 | 4 | CID000104739 | |
| Drug | deguelin | 2.30e-05 | 55 | 141 | 5 | CID000107935 | |
| Drug | AC1L3G3T | 2.48e-05 | 93 | 141 | 6 | CID000114866 | |
| Drug | Invader | 2.51e-05 | 56 | 141 | 5 | CID006442259 | |
| Drug | CARMINE | 2.57e-05 | 28 | 141 | 4 | CID000014749 | |
| Drug | erucin | 2.57e-05 | 28 | 141 | 4 | CID000078160 | |
| Disease | X-11442 measurement | 5.83e-08 | 9 | 139 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 5.83e-08 | 9 | 139 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 5.83e-08 | 9 | 139 | 4 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 5.83e-08 | 9 | 139 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 9.69e-08 | 10 | 139 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 9.69e-08 | 10 | 139 | 4 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 1.52e-07 | 11 | 139 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.52e-07 | 11 | 139 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.52e-07 | 11 | 139 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.52e-07 | 11 | 139 | 4 | EFO_0010219 | |
| Disease | biliverdin measurement | 2.27e-07 | 12 | 139 | 4 | EFO_0021033 | |
| Disease | gallstones | 8.30e-07 | 108 | 139 | 7 | EFO_0004210 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.02e-06 | 5 | 139 | 3 | DOID:3030 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.07e-06 | 17 | 139 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | cholelithiasis | 3.87e-06 | 88 | 139 | 6 | EFO_0004799 | |
| Disease | X-11793--oxidized bilirubin measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 5.63e-06 | 8 | 139 | 3 | EFO_0800766 | |
| Disease | urate measurement, spine bone mineral density | 8.09e-06 | 58 | 139 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 8.42e-06 | 9 | 139 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 8.42e-06 | 9 | 139 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 8.42e-06 | 9 | 139 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 8.42e-06 | 9 | 139 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 8.42e-06 | 9 | 139 | 3 | EFO_0802127 | |
| Disease | xanthurenate measurement | 1.02e-05 | 29 | 139 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.17e-05 | 30 | 139 | 4 | EFO_0600017 | |
| Disease | X-21448 measurement | 1.20e-05 | 10 | 139 | 3 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.20e-05 | 10 | 139 | 3 | EFO_0800867 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.64e-05 | 11 | 139 | 3 | DOID:0050564 (is_implicated_in) | |
| Disease | p-cresol glucuronide measurement | 2.18e-05 | 12 | 139 | 3 | EFO_0800079 | |
| Disease | cystitis (is_marker_for) | 2.20e-05 | 2 | 139 | 2 | DOID:1679 (is_marker_for) | |
| Disease | retinol dehydrogenase 16 measurement | 2.83e-05 | 13 | 139 | 3 | EFO_0802007 | |
| Disease | urinary bladder cancer (is_implicated_in) | 3.05e-05 | 76 | 139 | 5 | DOID:11054 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | PCSK5 DNAJC13 RAPSN UGT1A5 DGKZ SLC2A2 PPP1CC UGT1A4 UGT1A1 UGT1A3 MAP4K5 TSPAN14 ZNF471 | 3.44e-05 | 713 | 139 | 13 | EFO_0005689 |
| Disease | gastric ulcer (implicated_via_orthology) | 3.58e-05 | 14 | 139 | 3 | DOID:10808 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TBXAS1 ERBB2 COL11A1 DVL3 TECTA PTGS2 SLC2A2 OTOGL PIK3CB DIP2C OXSM SPEN GPR45 NOTCH2 ZNF541 AGAP2 | 4.85e-05 | 1074 | 139 | 16 | C0006142 |
| Disease | sputum mucin-5B amount | 6.59e-05 | 3 | 139 | 2 | OBA_2050332 | |
| Disease | Hashimoto Disease | 6.59e-05 | 3 | 139 | 2 | C0677607 | |
| Disease | angiopoietin-related protein 1 measurement | 7.93e-05 | 18 | 139 | 3 | EFO_0801382 | |
| Disease | body mass index, fasting blood glucose measurement | 9.92e-05 | 51 | 139 | 4 | EFO_0004340, EFO_0004465 | |
| Disease | tissue factor measurement | 1.28e-04 | 21 | 139 | 3 | EFO_0010623 | |
| Disease | Robinow Syndrome | 1.31e-04 | 4 | 139 | 2 | C0265205 | |
| Disease | Robinow Syndrome, Autosomal Dominant | 1.31e-04 | 4 | 139 | 2 | C4551476 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.33e-04 | 55 | 139 | 4 | C0079744 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.43e-04 | 105 | 139 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | BMI-adjusted fasting blood glucose measurement | 1.69e-04 | 23 | 139 | 3 | EFO_0008036 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.18e-04 | 5 | 139 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | 1-myristoyl-2-linoleoyl-GPC (14:0/18:2) measurement | 2.18e-04 | 5 | 139 | 2 | EFO_0800452 | |
| Disease | eosinophil percentage of leukocytes | RAPSN ADCY7 TG PIK3C2B PLXNC1 MAP4K5 C1S IL17RA MUC2 MUC5AC NOTCH2 DNMT3L | 2.23e-04 | 746 | 139 | 12 | EFO_0007991 |
| Disease | cholangiocarcinoma (is_marker_for) | 2.41e-04 | 64 | 139 | 4 | DOID:4947 (is_marker_for) | |
| Disease | bilirubin measurement | COL11A1 RAPSN UGT1A5 REV3L SLC2A2 UGT1A4 UGT1A1 UGT1A3 MAP4K5 | 2.58e-04 | 442 | 139 | 9 | EFO_0004570 |
| Disease | total lipids in very large HDL measurement | 2.71e-04 | 66 | 139 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 2.71e-04 | 66 | 139 | 4 | EFO_0022298 | |
| Disease | neutrophil count | SELP CPAMD8 DNAJC13 COL11A1 RAPSN OLFML2B TTC39C FFAR2 TSHB ZNF12 ZC3H7A MAP4K5 TSPAN14 IL17RA PMF1 NOTCH2 JAM3 | 2.81e-04 | 1382 | 139 | 17 | EFO_0004833 |
| Disease | cholesterol in very large HDL measurement | 3.22e-04 | 69 | 139 | 4 | EFO_0022229 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 3.26e-04 | 6 | 139 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | gondoic acid measurement | 3.26e-04 | 6 | 139 | 2 | EFO_0007975 | |
| Disease | serum urea measurement | 3.34e-04 | 195 | 139 | 6 | EFO_0009795 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 4.56e-04 | 7 | 139 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 6.06e-04 | 8 | 139 | 2 | EFO_0801971 | |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 6.06e-04 | 8 | 139 | 2 | EFO_0800455 | |
| Disease | hormone measurement | 6.80e-04 | 84 | 139 | 4 | EFO_0004730 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 7.76e-04 | 9 | 139 | 2 | EFO_0009824 | |
| Disease | Melancholia | 9.57e-04 | 41 | 139 | 3 | C0025193 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.57e-04 | 41 | 139 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.57e-04 | 41 | 139 | 3 | C0858252 | |
| Disease | Depression, Neurotic | 9.57e-04 | 41 | 139 | 3 | C0282126 | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0800608 | |
| Disease | gamma-glutamylthreonine measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0021143 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0800507 | |
| Disease | thrombosis (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | Head and Neck Carcinoma | 9.67e-04 | 10 | 139 | 2 | C3887461 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0800464 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 9.67e-04 | 10 | 139 | 2 | OBA_2045193 | |
| Disease | level of phosphatidylcholine | 9.67e-04 | 10 | 139 | 2 | OBA_2040179 | |
| Disease | colitis (biomarker_via_orthology) | 1.03e-03 | 42 | 139 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Depressive Syndrome | 1.03e-03 | 42 | 139 | 3 | C0086133 | |
| Disease | Autoimmune Diseases | 1.03e-03 | 42 | 139 | 3 | C0004364 | |
| Disease | Retinal Detachment | 1.18e-03 | 11 | 139 | 2 | C0035305 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0800269 | |
| Disease | Sodium measurement | 1.18e-03 | 11 | 139 | 2 | C0337443 | |
| Disease | Adverse Event by CTCAE Category | 1.18e-03 | 11 | 139 | 2 | C1879645 | |
| Disease | pregnenetriol sulfate measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0600039 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.18e-03 | 11 | 139 | 2 | DOID:9206 (is_marker_for) | |
| Disease | Mammary Ductal Carcinoma | 1.18e-03 | 11 | 139 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 1.18e-03 | 11 | 139 | 2 | C1134719 | |
| Disease | Endogenous depression | 1.34e-03 | 46 | 139 | 3 | C0011573 | |
| Disease | triacylglycerol 58:12 measurement | 1.41e-03 | 12 | 139 | 2 | EFO_0010439 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.41e-03 | 12 | 139 | 2 | EFO_0010378 | |
| Disease | triacylglycerol 53:2 measurement | 1.41e-03 | 12 | 139 | 2 | EFO_0021484 | |
| Disease | Papilloma | 1.41e-03 | 12 | 139 | 2 | C0030354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTVAFITFKCCAYGY | 501 | P35503 | |
| YVTSLCRCFGEQVTY | 486 | P54793 | |
| FGASCVTACPYNYLS | 291 | P04626 | |
| YNYLSTDVGSCTLVC | 301 | P04626 | |
| FCCYDYFAANDPTSI | 821 | P53355 | |
| YFGSVNASYNAIIDC | 1021 | Q9NY47 | |
| LYDDDGYQSYCSICC | 86 | Q9UJW3 | |
| GYQSYCSICCSGETL | 91 | Q9UJW3 | |
| CLFRQYATCFNSGIY | 51 | Q5QJU3 | |
| AAYLGCVCFAYFDAA | 221 | Q5QJU3 | |
| RYASLYFCCAIEGQD | 61 | P61966 | |
| ALGLFNIFLYTCCYT | 261 | Q12887 | |
| RCSYYETCATYGLNV | 541 | Q99490 | |
| YYTCSCVLGFIACSV | 721 | P51828 | |
| CYNYTGIADACDFLF | 191 | Q01459 | |
| FSEQCYYIFGDLCGN | 486 | Q92997 | |
| RYAGLYFCICVDVND | 61 | P53680 | |
| YFVYGAACSEVEIDC | 1161 | Q06278 | |
| FYCKLCGLFYTSEET | 1161 | Q5T481 | |
| CCSLGSFYAQVKDYE | 166 | Q13702 | |
| EDGYYFTNLCCAVAF | 351 | Q9UJ41 | |
| TIQYGCIAHCAFEYV | 16 | Q96LU5 | |
| DGSYCYECTARFGVT | 1106 | Q9P2R3 | |
| GAVEAAFTTLACYYQ | 391 | Q9NWU1 | |
| LVFGYNCCKVGASNY | 221 | Q8NEZ5 | |
| YDFSGTCNYIFAATC | 61 | Q6W4X9 | |
| DYVNSYTCKCQAGFD | 966 | Q04721 | |
| ISFAGCFTQCYIFIA | 91 | Q96RB7 | |
| FGTYVVCYFSEVSCD | 496 | Q96F46 | |
| VCALTSFGFYSSIYC | 81 | O15552 | |
| FVCQCYSGYALAEDG | 301 | O00339 | |
| EICYSVLCLFSYVAA | 1616 | Q8WXG6 | |
| YCFVFALGYLTVCQV | 101 | Q6ZWT7 | |
| IISYFCSLGCYVNSS | 396 | Q96L50 | |
| FLQEECCYYLNESGV | 496 | P60608 | |
| CCYYLNESGVVENSL | 501 | P60608 | |
| TADCSYQSYFSGACC | 616 | Q5VTL7 | |
| TAVYACCNPIQETYF | 656 | Q9NQG7 | |
| IIYCNDGFCELFGYS | 41 | Q9H252 | |
| LVFFSTCACVEYYGK | 271 | Q8NHQ9 | |
| KVYCNFTSGGETCIY | 1636 | P12107 | |
| TTACVCADTVYYYQM | 616 | Q63HM2 | |
| DGRCVQSCSISYYFD | 811 | Q92824 | |
| NVSEYCVATYCGFLA | 796 | O60486 | |
| NTCGSHVCAVLAYYV | 241 | Q9H342 | |
| NFIYSCAGCCVATYV | 1231 | O00443 | |
| NGTYGDTCYFVNCSL | 4351 | Q02817 | |
| QCIYTGGSSYTCSCL | 776 | P14543 | |
| ALCFQYIADFCGPYV | 451 | P11168 | |
| AAGSYQRFTDCYKCF | 51 | Q6P1K2 | |
| GFDQYKCDCTRTGFY | 36 | P35354 | |
| GLCNYVFSEHCGAAY | 101 | P98088 | |
| VSKCACVYNGAAYAP | 391 | P98088 | |
| QYYCIASNDAGSARC | 216 | Q9BX67 | |
| IVDFAGYCAQNGFYC | 271 | P51617 | |
| FYCGSSFYATSTCVL | 296 | Q9Y5Y3 | |
| NFIYSCAGCCVATYV | 1176 | O00750 | |
| TEAAYFAYLLCVCVS | 346 | P25116 | |
| GCGAQLFFSCVVAYT | 111 | Q8NGQ1 | |
| CASHFTYVVIGYGSC | 241 | Q8NGU1 | |
| ECASINRIYGFYDEC | 126 | P62136 | |
| ETYLYACLVDFFSGC | 131 | Q86YG4 | |
| VFIAAACVAYYGAFT | 2996 | Q9C0G6 | |
| LCGNDSVYAYASSVF | 286 | Q9BYW1 | |
| TVGVQGDCRSYSYVC | 516 | P49915 | |
| CPDYVSAGENSCYFN | 101 | P10912 | |
| LCAFRCVNTYGSYEC | 2216 | P35555 | |
| SAQPCDSIVVAYYFC | 776 | O15169 | |
| STCPCNFTLYYEVAA | 476 | Q8IZJ3 | |
| YCCVFYGQSFCQGST | 251 | Q58HT5 | |
| TGFAAYYVATDINEC | 121 | P09871 | |
| GELCVCAVATGTSYY | 731 | Q9Y2E4 | |
| VQVCGYISKCYSVAA | 1471 | O75165 | |
| SYKSTCQFICDEGYS | 531 | P16109 | |
| ICYDYDLCASCYESG | 26 | Q9P0J7 | |
| EQCYYVFGDLCSNLA | 491 | O14640 | |
| YRCTAVNAYGEAACS | 101 | Q86VF2 | |
| GFCVFESNAIAYYVS | 66 | P26641 | |
| SGDFCYVGEQYCVAR | 106 | Q13574 | |
| SSFSYHEASGYVCIC | 371 | P82279 | |
| EQCYYVFGDLCSNLA | 466 | P54792 | |
| CTCEEQYVGTFCEEY | 336 | Q8NFT8 | |
| TECYRIYEACSYGSI | 336 | Q9Y2B1 | |
| YVADTCRCFFERGYS | 791 | Q68D06 | |
| EVTLTCLLNFSCYGY | 156 | P20273 | |
| ECKHCNIVAYFGSYL | 71 | Q9Y4K4 | |
| GDCECLCTSIAAYAY | 1171 | Q3ZCN5 | |
| FTCVVIGYGSCLFLY | 241 | Q8NGT5 | |
| EYLYTDSCCPAGIFQ | 476 | O94955 | |
| YIVTPCADYFCCESD | 186 | Q6ZN16 | |
| QEYSYQLKACTVAGC | 3561 | O75445 | |
| TCLFLGEECCYYVNQ | 396 | Q9UQF0 | |
| GEECCYYVNQSGIVT | 401 | Q9UQF0 | |
| VRFYCYSLACQAGLT | 86 | Q6PIV7 | |
| YAIYDFIVKGSCFCN | 251 | Q9HB63 | |
| YGVCNVISITCAYTS | 171 | Q8TBE7 | |
| VCSTAAFLGVYYALD | 326 | Q8TBE7 | |
| VCSRQIYFVACTVAY | 466 | Q8IUH8 | |
| GSNIISYFYCDCIPL | 176 | Q8NGG5 | |
| VGACVSSVCVNYESF | 751 | Q9Y6Y8 | |
| FTLSCAGYCVASYVL | 901 | P42338 | |
| CFVICGVLYAVDSYN | 676 | Q68BL8 | |
| SYVGCLVQCYFFIAV | 91 | Q8NGP3 | |
| VLATSGYVFCYRCVF | 316 | O00623 | |
| RNFVQSCAGYCLVCY | 651 | Q9UBF8 | |
| CITQCYFYFFLGTVE | 96 | Q8NGC5 | |
| VDSYYCACKQGFLSS | 51 | Q14246 | |
| SVYCGFNAVCYNVEG | 76 | Q9BY15 | |
| FNAVCYNVEGSFYCQ | 81 | Q9BY15 | |
| ISFVGYINSGCCNIY | 356 | Q8NA66 | |
| FQAAVERFVYSCAGY | 921 | P48736 | |
| ERFVYSCAGYCVATF | 926 | P48736 | |
| CIQCGKFFCYYSGFT | 441 | P17032 | |
| YCQARTDASCIVSGY | 1091 | O75443 | |
| CTYFGCLVQDYVSFL | 526 | Q8WYP3 | |
| CYCNYTTDVVASVAF | 181 | P24557 | |
| YQFRYCGHCNTTTDI | 526 | Q8N5D0 | |
| YVCNECGKAFTCSSY | 446 | P13682 | |
| EGAVNPESCYYYCAV | 1011 | Q86UP3 | |
| QTYCGSFAYACPEIL | 196 | Q6SA08 | |
| CEECGKAFYQYSNLT | 536 | A8MTY0 | |
| PQYAFLQYCDIASVC | 476 | Q96T58 | |
| LTCTVVAVCYGSFYN | 531 | Q969N2 | |
| SIVIAYNYCFSTCLG | 2621 | O60673 | |
| YNYCFSTCLGHVENL | 2626 | O60673 | |
| FYQRACLSGYCSAFA | 736 | Q12767 | |
| VAAKCYLGATCAYDA | 1041 | Q8TEQ6 | |
| YVIDTANSACVGSAY | 461 | O75191 | |
| TVAFITFKCCAYGYR | 501 | P22309 | |
| LTVAFITFKCCAYGY | 501 | P35504 | |
| YNSDVVSECSYCGAR | 411 | Q5T7W7 | |
| ECASINRIYGFYDEC | 126 | P36873 | |
| GFFVSIIYCYCNGEV | 406 | P49190 | |
| CAYCLTINTTICAGY | 36 | P01222 | |
| PYSYGNIFTNCCVAL | 301 | Q8IZN3 | |
| YYSCHVCGFETELNV | 896 | Q17R98 | |
| CNECGKVFSYYSCLA | 511 | Q6ZN19 | |
| RYSGHCTFAYCQEEI | 516 | Q8IWR0 | |
| YECIECGKAFRYNTS | 346 | Q9BX82 | |
| FCCGISVYLAALSIY | 126 | A6NGB7 | |
| YECNYCGATFSRSSI | 691 | Q8TF39 | |
| LENYSNLVSVGYCCF | 76 | Q9Y2H8 | |
| STGVAIACCAAVYYL | 626 | Q6UXY8 | |
| VYFNCSGASYSREKC | 166 | Q8NG11 | |
| YECSECGKTFYQNSA | 521 | P17014 | |
| GICCVYEVFIAQGYT | 196 | Q6ZXV5 | |
| SQCYYAYLTAVCQGA | 386 | Q8N584 | |
| SVYGSVYAIADVAFC | 416 | Q05940 | |
| EYAYVTVCNQCGRES | 216 | Q86UV5 | |
| YFTCTLYPEAQVCDD | 1916 | P01266 | |
| YVCGECGKAFSQSSY | 326 | Q9NQZ8 | |
| FVCIEQGCSKSYCDY | 196 | Q9H0D2 | |
| LTVAFITFKCCAYGY | 501 | P22310 | |
| VGYRCNCYFISSEQK | 66 | Q13241 | |
| TYGIIFACGCSFAYQ | 171 | Q8TF71 |